Furthermore, glioma with mutations in the isocitrate dehydrogenase (IDH) enzyme (IDH‐mutant), which could cause accumulation of the oncometabolite 2HG, has been the focus of recent research using 1H‐MRS/I. This evidence concerns the gene IDH1 and central nervous system cancer.